• Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from Analysts

    来源: Buzz FX / 13 1月 2025 01:31:15   America/Chicago


    Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Regeneron Pharmaceuticals, Inc.
    Read more...
分享